A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
CL Lorson, E Hahnen… - Proceedings of the …, 1999 - National Acad Sciences
SMN1 and SMN2 (survival motor neuron) encode identical proteins. A critical question is
why only the homozygous loss of SMN1, and not SMN2, results in spinal muscular atrophy (…
why only the homozygous loss of SMN1, and not SMN2, results in spinal muscular atrophy (…
Association analysis identifies 65 new breast cancer risk loci
…, A Grundy, P Guenel, L Haeberle, E Hahnen… - Nature, 2017 - nature.com
Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as
BRCA1, and many common, mostly non-coding variants. However, much of the genetic …
BRCA1, and many common, mostly non-coding variants. However, much of the genetic …
[PDF][PDF] Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
…, A Grundy, P Guénel, L Haeberle, E Hahnen… - The American Journal of …, 2019 - cell.com
Stratification of women according to their risk of breast cancer based on polygenic risk scores
(PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, …
(PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, …
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
…, E Stickeler, L Michel, O Stötzer, E Hahnen… - The Lancet …, 2021 - thelancet.com
Background The development of anti-HER2 antibody–drug conjugates opens new therapeutic
options for patients with breast cancer, including patients with low expression of HER2. …
options for patients with breast cancer, including patients with low expression of HER2. …
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
…, B Wappenschmidt, A Becker, K Rhiem, E Hahnen… - Jama, 2015 - jamanetwork.com
Importance Limited information about the relationship between specific mutations
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …
SMN oligomerization defect correlates with spinal muscular atrophy severity
…, J Strasswimmer, JM Yao, JD Baleja, E Hahnen… - Nature …, 1998 - nature.com
Spinal muscular atrophy (SMA) is a motor-neuron disorder resulting from anterior-horn–cell
death. The autosomal recessive form has a carrier frequency of 1 in 50 and is the most …
death. The autosomal recessive form has a carrier frequency of 1 in 50 and is the most …
Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the GeparSixto …
E Hahnen, B Lederer, J Hauke, S Loibl, S Kröber… - JAMA …, 2017 - jamanetwork.com
Importance The GeparSixto trial provided evidence that the addition of neoadjuvant
carboplatin to a regimen consisting of anthracycline, taxane, and bevacizumab increases …
carboplatin to a regimen consisting of anthracycline, taxane, and bevacizumab increases …
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
…, EL Goode, SB Gruber, E Hahnen… - Journal of clinical …, 2020 - ascopubs.org
PURPOSE To estimate age-specific relative and absolute cancer risks of breast cancer and
to estimate risks of ovarian, pancreatic, male breast, prostate, and colorectal cancers …
to estimate risks of ovarian, pancreatic, male breast, prostate, and colorectal cancers …
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
…, MH Greene, J Gronwald, S Gruber, E Hahnen… - Nature …, 2017 - nature.com
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC),
we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC …
we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC …
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
…, L Golmard, MH Greene, E Hahnen… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide precise age-specific risk estimates of cancers other than female breast
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …